Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00343057
Other study ID # IXP0001A_9001
Secondary ID
Status Completed
Phase N/A
First received June 20, 2006
Last updated September 3, 2009
Start date September 2003
Est. completion date June 2004

Study information

Verified date September 2009
Source Sanofi
Contact n/a
Is FDA regulated No
Health authority France : Not applicable
Study type Observational

Clinical Trial Summary

To assess the impact of standardized written information on outcome in acute LBP.


Description:

A 3-month prospective, controlled study with a quasi-experimental design (i.e., a nonrandomized controlled sample with geographic stratification [30 areas]). Control and intervention areas ARE selected for their similarities in rural-to-urban distribution of the population and patients' access to GPs and to minimize risk of overlap between areas.


Recruitment information / eligibility

Status Completed
Enrollment 2830
Est. completion date June 2004
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Each GP have to enroll up to 4 patients with acute LBP.

Exclusion Criteria:

Patients are excluded if they

1. are less than 18 years old;

2. have pain for more than 4 weeks;

3. have pain intensity for the previous 24 hours less than 3 on a 11-point numeric scale (0= no pain, 10=maximal pain);

4. have sciatica;

5. have had a previous episode of acute LBP during the last 12 months;

6. have no occupational activities;

7. have consulted another practitioner for the same episode of back pain;

8. are pregnant;

9. have back pain related to infection, tumor, or inflammatory disease; or (j) have previously undergone back surgery.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Other:
Patients' questionnaire


Locations

Country Name City State
France Sanofi-Aventis Paris

Sponsors (1)

Lead Sponsor Collaborator
Sanofi

Country where clinical trial is conducted

France, 

See also
  Status Clinical Trial Phase
Completed NCT00010985 - Usual Care Vs Choice of Alternative Rx: Low Back Pain Phase 3
Completed NCT00000418 - Psychosocial Treatment for Acute Low Back Pain Phase 2
Completed NCT06022484 - Magnetic Resonance Imaging and Acute Low Back Pain
Completed NCT01708915 - Nonivamide/Nicoboxil Ointment in Acute Low Back Pain Phase 3
Completed NCT00782925 - An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers N/A
Completed NCT04968158 - Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain Phase 3
Completed NCT05001555 - Efficacy and Safety of Dexketoprofen/Vitamin B vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Phase 3
Completed NCT03424707 - A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain Phase 2
Recruiting NCT04328428 - The Evaluation of Single Acupoint Therapy to Acute Low Back Pain N/A
Completed NCT00643383 - A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain Phase 3
Completed NCT02517762 - Acute Low Back Pain: Causes, Mechanisms, Treatment and Followup N/A
Completed NCT04772781 - Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain Phase 2
Completed NCT00706043 - French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire
Completed NCT00525811 - Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression N/A
Completed NCT04575714 - Clinical Pathways and Patients' Attitudes in Acute Low Back Pain
Completed NCT03341832 - Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain Phase 2
Completed NCT00952068 - A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day Phase 2
Completed NCT04082975 - Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain Phase 3
Recruiting NCT02037763 - A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain N/A
Completed NCT01638286 - Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects N/A